Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET ☆
Titel:
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET ☆
Auteur:
Gennari, A. Brain, E. De Censi, A. Nanni, O. Wuerstlein, R. Frassoldati, A. Cortes, J. Rossi, V. Palleschi, M. Alberini, J.L. Matteucci, F. Piccardo, A. Sacchetti, G. Ilhan, H. D’Avanzo, F. Ruffilli, B. Nardin, S. Monti, M. Puntoni, M. Fontana, V. Boni, L. Harbeck, N.